Showing results (471-480 of 992) with videos related to
Sort By:
Pageof 100
Journal of Opioid Management|September 25, 2024
Partial Agonist, Full Barrier: A Case-Based Discussion on Challenges with Buprenorphine in Chronic Pain ManagementTonya S Hershman, Michelle ParkJournal of Opioid Management|September 25, 2024
Overcoming challenges of prescribing long-term opioid therapy in residency clinicsKathryn Brown, Joel Farley, Ezra Golberstein, et al.Journal of Opioid Management|September 25, 2024
Association between buprenorphine capacity rates and percentages of ethnic/racial minorities at the county level in the United StatesSaharnaz Nedjat, Marc FlemingJournal of Opioid Management|September 25, 2024
Buprenorphine: Opioid Agonist-Antagonist for Refractory Pain of Sickle Cell Disease Patients During Hematopoietic Stem Cell Transplant, Uncontrolled By Full-Agonist OpioidsMayuko SakaeJournal of Opioid Management|September 25, 2024
The influence of guidelines on opioid prescribing practices after pe-diatric anterior cruciate ligament reconstructionTanner Hudson, Fehmi Berkay, Arjun Minhas, et al.Journal of Opioid Management|September 25, 2024
Buprenorphine: Not Just Another Opioid - Understanding the World's Most Interesting OpioidAndrea RubinsteinJournal of Opioid Management|September 25, 2024
Implementing a text-message-based intervention to increase access to naloxone for patients on chronic opioid therapyScott G Weiner, Salah Alrakawi, Morgan Kelley, et al.Journal of Opioid Management|March 3, 2026
Systematic review of real-world data associated with opioid scheduling and nonmedical useSuzanne K Vosburg, Taryn Dailey-Govoni, Jody L GreenJournal of Opioid Management|March 3, 2026
Slow opioid tapering compared to continued stable opioid therapy for chronic noncancer pain: A double-blinded randomized controlled trialBenjamin Lai, Brandon Hidaka, Mohammad Aziz, et al.Journal of Opioid Management|March 3, 2026
Formulation development and a Phase 1 clinical study of PF614-MPAR, an oxycodone prodrug with oral opioid overdose protectionD Lynn Kirkpatrick, Linda A Pestano, Cari Evans, et al.Pageof 100